Industry News
Expedeon AG signs commercial agreement with Sona Nanotech
Agreement will address limitations in development of multiplex point-of-care Lateral Flow Assay diagnostic tests
Agreement will address limitations in development of multiplex point-of-care Lateral Flow Assay diagnostic tests
This novel antibody labeling immunoassay for multiplex immune profiling aims to address one of the fastest growing, billion-dollar life science market sectors
Expedeon’s technology directly conjugates antibodies to enzymes, small molecules and fluorescent dyes